PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
about
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@en
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@nl
type
label
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@en
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@nl
prefLabel
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@en
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
@nl
P2093
P2860
P1476
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
@en
P2093
Hui-Li Chu
Jingwang Bi
Li-Li Wang
Qing-Hua Ma
Shi-Wei Zhao
Ting-Ting Shi
Yan-Long Shi
Yu-Lin Liu
P2860
P356
10.1038/S41419-018-0776-6
P50
P577
2018-07-03T00:00:00Z